Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

Businesses and academia need to pool resources in order to close the digital skills gap.

Science Capital and HealthCare Innovation Daily invite you to Innovative Healthcare: From design to delivery.…

Will encouraging small web-based news providers deliver more effective public interest reporting than subsidising…

This week's healthcare conversation - the NHS internal market, 24 years old and still a mystery, the endlessly…

There are many reasons for opening up data, economic, political, social. But serendipitous outcomes, unforeseen…

Like it or loathe it the NHS has an internal market, and it is the job of CCGs to make this market work in the…

A British exit, or Brexit, from the European Union in a few years’ time looks increasingly possible. It…

A new report from the Information Commissioner's Office highlights a wider underlying issue concerning data within businesses.

Do you do digital? Take the test

The Information Daily is collaborating with Socitm to research organisations' commitment to and capability for a digital future.

Take the test

View Results

If you have already taken the test, you may view the latest detailed results by entering your email address below


Headline results so far: Results from 106 users

Corporate commitment: 47%
0%
100%
50%
Digital capability: 53%
0%
100%
50%

By adopting mobile health care (mHealth) solutions, health service providers are better equipped to manage their…

PODCAST - REALITYBITES 02 : Ben Gowland, CEO Nene CCG and Joe Tibbetts in conversation, Topics for today GPs "day…

The RealityBites Podcast will be published each week on Monday morning and will be accessible and downloadable…

NICE has to make difficult decisions because there is not enough money in the NHS, and it plays a critical role…